Overview
Minghai Tang practices in Chengdu, China. Tang is rated as an Advanced expert by MediFind in the treatment of Myeloproliferative Neoplasms (MPN). Their top areas of expertise are Myeloproliferative Neoplasms (MPN), Phenylketonuria (PKU), Secondary Peritonitis, Peritonitis, and Reconstructive Urology Surgery.
Their clinical research consists of co-authoring 132 peer reviewed articles. MediFind looks at clinical research from the past 15 years. In particular, they have co-authored 6 articles in the study of Myeloproliferative Neoplasms (MPN).
Locations
Clinical Research
Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.
Areas of Expertise
MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.
Learn more about MediFind’s expert tiers
- Advanced
- Myeloproliferative Neoplasms (MPN)
- Experienced
- Acute Myeloid Leukemia (AML)
- ArthritisTang isExperienced. Learn about Arthritis.
- B-Cell LymphomaTang isExperienced. Learn about B-Cell Lymphoma.
- Burkitt LymphomaTang isExperienced. Learn about Burkitt Lymphoma.
- Chronic Myelogenous Leukemia (CML)
- Idiopathic Pulmonary Fibrosis